[go: up one dir, main page]

ES2077530A1 - Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. - Google Patents

Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.

Info

Publication number
ES2077530A1
ES2077530A1 ES09350011A ES9350011A ES2077530A1 ES 2077530 A1 ES2077530 A1 ES 2077530A1 ES 09350011 A ES09350011 A ES 09350011A ES 9350011 A ES9350011 A ES 9350011A ES 2077530 A1 ES2077530 A1 ES 2077530A1
Authority
ES
Spain
Prior art keywords
pharmaceutical products
curing
preparing same
tumorous diseases
ppm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09350011A
Other languages
English (en)
Other versions
ES2077530B1 (es
Inventor
G Bor Somlyai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HYD Kutato-Fejleszto Kft
Original Assignee
HYD Kutato-Fejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HYD Kutato-Fejleszto Kft filed Critical HYD Kutato-Fejleszto Kft
Publication of ES2077530A1 publication Critical patent/ES2077530A1/es
Application granted granted Critical
Publication of ES2077530B1 publication Critical patent/ES2077530B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE PRODUCTOS FARMACEUTICOS PARA CURAR ENFERMEDADES TUMORALES. LA INVENCION SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE PRODUCTOS PARA CURAR ENFERMEDADES TUMORALES QUE INCLUYEN COMO AGENTE ACTIVO AGUA O SOLUCIONES ACUOSAS, SON APROPIADOS PARA EL CONSUMO HUMANO, TIENEN UN CONTENIDO DE DEUTERIO COMPRENDIDO ENTRE 0,1 Y 110 PPM, OPCIONALMENTE JUNTO CON PORTADORES Y/O SUSTANCIAS AUXILIARES, Y ADOPTAN LA FORMA DE PRODUCTOS FARMACEUTICOS O SOLUCIONES MEDICINALES.
ES09350011A 1991-10-31 1992-09-28 Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales. Expired - Fee Related ES2077530B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases

Publications (2)

Publication Number Publication Date
ES2077530A1 true ES2077530A1 (es) 1995-11-16
ES2077530B1 ES2077530B1 (es) 1996-07-01

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09350011A Expired - Fee Related ES2077530B1 (es) 1991-10-31 1992-09-28 Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.

Country Status (22)

Country Link
US (1) US5855921A (es)
JP (1) JP3569916B2 (es)
KR (1) KR100253874B1 (es)
CN (1) CN1045162C (es)
AT (1) AT402692B (es)
BE (1) BE1006186A3 (es)
CA (1) CA2122612C (es)
CH (1) CH685282A5 (es)
CZ (1) CZ282379B6 (es)
DE (1) DE4232465B4 (es)
DK (1) DK170832B1 (es)
ES (1) ES2077530B1 (es)
FI (1) FI114010B (es)
FR (1) FR2683148B1 (es)
GB (1) GB2276086B (es)
HU (1) HU208084B (es)
IT (1) IT1255390B (es)
LU (1) LU88175A1 (es)
NL (1) NL194664C (es)
NO (1) NO307031B1 (es)
SE (1) SE513624C2 (es)
WO (1) WO1993008794A1 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69428213T2 (de) * 1994-01-06 2002-06-13 Hyd Kutato-Fejleszto Ktf, Budapest Nahrungsmittel zur verhinderung der entwicklung von erkrankungen und verfahren zur herstellung dieser nahrungsmittel
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
TWI263677B (en) * 2002-02-12 2006-10-11 Univ California Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolic products
JP4804753B2 (ja) 2002-07-30 2011-11-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 質量分析法を使用した、プロテオームまたはオルガネオームの分子フラックス速度の自動化大規模測定
WO2004022098A1 (en) * 2002-09-09 2004-03-18 Borsos Ferenc Oxygen-enriched water, treated within a magnetic field and heavy water
EP1546373B1 (en) * 2002-09-13 2008-11-26 The Regents of the University of California Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
CA2504313C (en) 2002-11-04 2012-01-17 Marc K. Hellerstein Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
AU2005327332B2 (en) 2005-02-08 2010-07-22 Woodford Associates Limited Non-alcoholic beverage enriched with 1H216O
EP1846546B1 (en) * 2005-02-08 2011-04-13 Woodford Associates Limited Alcoholic beverage enriched with 1h216o
BRPI0520147A2 (pt) * 2005-03-05 2009-04-22 Sergey Pavlovich Soloviev composiÇÕes cosmÉticas enriquecidas com 1h2 16o
EA012822B1 (ru) * 2005-03-11 2009-12-30 Вада Консалтинг Лимитед Композиции для дезинфекции поверхностей неодушевленных предметов
JP2008533003A (ja) * 2005-03-11 2008-08-21 ヴァーダ コンサルティング リミテッド 製薬用軽水、治療用組成物及びその方法
EA012187B1 (ru) * 2005-03-11 2009-08-28 Вада Консалтинг Лимитед Способы для интрадермальной, трансдермальной или трансмукозальной доставки биологически активных веществ
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
RU2287324C1 (ru) * 2005-04-29 2006-11-20 Тамази Владимирович Баззаев Мазь для лечения ожоговых ран
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
EP1971350A1 (en) * 2005-12-12 2008-09-24 VADA Consulting Limited Method of treating metabolic syndrome
US20080299221A1 (en) * 2005-12-12 2008-12-04 Igor Anatolievich Pomytkin Method for Decreasing Postprandial Glucose Excursion
EA014535B1 (ru) * 2005-12-12 2010-12-30 Тимантти Аб Способ подавления аппетита и снижения объема поглощения пищи
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE102009017966A1 (de) 2009-04-21 2010-11-04 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
WO2012166459A1 (en) * 2011-05-27 2012-12-06 Bristol-Myers Squibb Company Tripeptides incorporating deuterium as inhibitors of hepatitis c virus
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
EP3435088A1 (en) 2011-12-07 2019-01-30 GlaxoSmithKline LLC Methods for determining total body skeletal muscle mass
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
WO2014088441A1 (en) * 2012-12-03 2014-06-12 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
EP3160590B1 (en) * 2014-06-30 2018-04-25 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
CN109843407A (zh) * 2016-09-21 2019-06-04 安布罗休斯·坎波利斯 同位素组合物
CN111867969A (zh) 2018-01-02 2020-10-30 植物水科技Ip有限公司 同位素组合物ii
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用
CN120078803A (zh) * 2025-03-05 2025-06-03 江苏睿景生物技术有限公司 低氘水对肿瘤细胞生长抑制的作用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332826A1 (en) * 1988-02-03 1989-09-20 Teva Pharmaceutical Industries Limited Injectable pharmaceutical compositions having improved stability, and methods of producing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332826A1 (en) * 1988-02-03 1989-09-20 Teva Pharmaceutical Industries Limited Injectable pharmaceutical compositions having improved stability, and methods of producing the same

Also Published As

Publication number Publication date
US5855921A (en) 1999-01-05
WO1993008794A1 (en) 1993-05-13
HU208084B (en) 1993-08-30
KR930007461A (ko) 1993-05-20
GB9408654D0 (en) 1994-07-20
CA2122612A1 (en) 1993-05-13
FR2683148A1 (fr) 1993-05-07
CN1071836A (zh) 1993-05-12
FI941979A0 (fi) 1994-04-29
SE9401406D0 (sv) 1994-04-25
FI941979L (fi) 1994-06-29
CZ102094A3 (en) 1994-12-15
FR2683148B1 (fr) 1994-09-09
BE1006186A3 (fr) 1994-06-07
AT402692B (de) 1997-07-25
FI114010B (fi) 2004-07-30
DE4232465B4 (de) 2008-11-06
NO307031B1 (no) 2000-01-31
GB2276086A (en) 1994-09-21
JP3569916B2 (ja) 2004-09-29
ITMI922233A0 (it) 1992-09-28
CA2122612C (en) 2003-02-04
KR100253874B1 (ko) 2000-04-15
NL194664B (nl) 2002-07-01
JPH08501275A (ja) 1996-02-13
DK170832B1 (da) 1996-02-05
HU913437D0 (en) 1992-01-28
LU88175A1 (fr) 1993-03-15
SE9401406L (sv) 1994-06-07
ITMI922233A1 (it) 1994-03-28
NL194664C (nl) 2002-11-04
ATA902992A (de) 1996-12-15
ES2077530B1 (es) 1996-07-01
NL9220026A (nl) 1994-09-01
GB2276086B (en) 1995-09-27
IT1255390B (it) 1995-10-31
CN1045162C (zh) 1999-09-22
CH685282A5 (de) 1995-05-31
CZ282379B6 (cs) 1997-07-16
NO941590L (es) 1994-06-23
SE513624C2 (sv) 2000-10-09
NO941590D0 (es) 1994-04-29
DE4232465A1 (de) 1993-05-06

Similar Documents

Publication Publication Date Title
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
ES2074124T3 (es) Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal.
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
ES2177636T3 (es) Utilizacion del agua empobrecida en deuterio en la preparacion de cosmeticos.
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
ES2173868T3 (es) Utilizacion de relaxina para la fabricacion de un medicamento destinado al tratamiento de enfermedades cardiovasculares.
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
UY26456A1 (es) Compuestos que fijan la estructura g-cuadruplex de los telomeros, triazinas de aplicación de dichos compuestos, la utilización de dichos compuestos como productos farmacéuticos y las asociaciones terapéuticas que los incluyen.
ES2098496T3 (es) Forma medicamentosa aplicable por via peroral para el tratamiento de estados de insuficiencia de dopamina en el sistema nervioso central.
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
BR0110486A (pt) Antranilamidas e sua aplicação como medicamento
ATE289805T1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
AR021086A1 (es) Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento.
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
DE69103624D1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
ES2138602T3 (es) Agente terapeutico para la amenaza de aborto.
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
BR0010668A (pt) Dióxidos de o-arilditiazol
ES2031930T3 (es) Un metodo para obtener una preparacion liofilizada que contiene aspoxicilina como ingrediente activo.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
MX9603241A (es) Productos farmaceuticos para curar enfermedades tumorales y procedimiento para su preparacion.
MX9703839A (es) Soluciones intravenosas de lubeluzol.
Nicholson Ask the doctor. In your article on Alzheimer's disease (March, 1999), you mention" high doses of vitamin E" as helpful in slowing the progression of the condition. Specifically, what dose is recommended?

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20141120